Related Experiment Video
Updated: Aug 1, 2026

12:35
In vivo Liver Endocytosis Followed by Purification of Liver Cells by Liver Perfusion
Published on: November 10, 2011
19.0K
Macaque liver substrate for evaluating dense fine speckled-like patterns on HEp2010 cells.
Anthea Anantharajah1, Roger A Silvestrini1, David Campbell1
1Department of Immunopathology - ICPMR, Westmead Hospital, Westmead, NSW, Australia.
Pathology
|August 21, 2024
Summary
Dense fine speckled (DFS) antinuclear antibody (ANA) patterns can mask other clinically relevant findings. Using a liver substrate alongside HEp2010 in indirect immunofluorescence assays helps rule out other extractable nuclear antigen (ENA) antibodies in DFS-like patterns.
Area of Science:
- Immunology
- Autoimmunity
- Clinical Diagnostics
Background:
- Antinuclear antibody (ANA) detection via indirect immunofluorescence (IIF) is crucial for diagnosing systemic autoimmune diseases (SADs).
- Dense fine speckled (DFS) ANA patterns typically indicate anti-DFS70 antibodies, which are generally associated with the absence of SAD.
- However, DFS patterns can obscure other potentially significant ANA patterns.
Purpose of the Study:
- To investigate if negative liver nucleus immunofluorescence can exclude extractable nuclear antigen (ENA) antibodies in sera exhibiting DFS-like ANA patterns.
- To evaluate the utility of a liver substrate in conjunction with HEp2010 for comprehensive ANA screening.
Main Methods:
- One hundred consecutive sera with DFS-like ANA patterns and 15 control sera were analyzed.
- Samples were examined on HEp2010 and liver substrates by two independent readers using IIF.
- Anti-DFS70 antibodies were quantified using line and chemiluminescent immunoassays.
Main Results:
- DFS-like sera were more frequently liver nucleus-negative than control sera.
- Among liver-negative sera, 95.3% were negative for anti-ENA antibodies.
- The liver substrate demonstrated a sensitivity of 90.0% and a negative predictive value of 95.4% for anti-ENA detection.
Conclusions:
- Concurrent evaluation using a liver substrate aids in ruling out other anti-ENA antibodies in cases with DFS-like ANA patterns.
- This approach serves as a safeguard against masking of clinically relevant anti-ENA by DFS-like patterns on IIF.
- The liver substrate enhances the diagnostic accuracy of ANA testing in complex cases.

